The role of CXCR2 in cancer-related MDSCs expansion has been already described in preclinical models, which showed that CXCR2 signaling in the Ly6G+ MDSCs promotes pancreatic tumorigenesis and is required for pancreatic cancer metastasis42. This evidence concerns the gene CXCR2 and cancer.